This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Biology Centre Cas, V.v.i., The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Georgia Research Foundation Inc. Active years: 2016.
Company Filing History:
1 out of 1 
1 out of 3,690 
1 out of 870 Years Active: 2016
Title: Michail Kotsyfakis: Innovator in Anticoagulant Research
Introduction
Michail Kotsyfakis is a notable inventor based in Ceske Budejovice, Czech Republic. He has made significant contributions to the field of biochemistry, particularly in the development of novel proteins with therapeutic applications. His work has implications for medical treatments, especially in anticoagulation therapy.
Latest Patents
Kotsyfakis holds a patent for a novel protein known as simukunin. This invention includes a protein that inhibits the function of several physiologically important enzymes. Simukunin is recognized as a potent inhibitor of the blood coagulation cascade, specifically targeting Factor Xa and functioning as an efficient anticoagulant. Additionally, simukunin inhibits serine proteases elastase and cathepsin, demonstrating anti-inflammatory properties. The patent also outlines methods for making and using simukunin.
Career Highlights
Throughout his career, Kotsyfakis has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the Biology Centre Cas, V.v.i. His research has contributed to advancements in understanding blood coagulation and inflammation.
Collaborations
Kotsyfakis has collaborated with notable professionals in his field, including Hitoshi Tsujimoto and Donald Champagne. These collaborations have enhanced the scope and impact of his research.
Conclusion
Michail Kotsyfakis is a distinguished inventor whose work on simukunin has the potential to transform anticoagulation therapy. His contributions to biochemistry and collaborations with esteemed colleagues highlight his commitment to advancing medical science.